Alectinib Hydrochloride

Records for this ingredient, by country (identity only).

ATC L01XE36 · 3 markets · 3 records

Alectinib Hydrochloride 3 markets · 3 records Forms

Filters

MarketAU 1 SG 1 FR 1

Strength

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

161.33 mgcapsuleALECENSA alectinib hydrochloride 150 mg hard capsule blister pack unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

150 mgcapsuleALECENSA HARD CAPSULE 150MG also in FR

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

150 mgcapsuleALECENSA 150 mg, gélule also in SG

Side-by-side table

Strength / form / release	AU	SG	FR
150 mg capsule	not recorded	ALECENSA HARD CAPSULE 150MG	ALECENSA 150 mg, gélule
161.33 mg capsule	ALECENSA alectinib hydrochloride 150 mg hard capsule blister pack	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.